Leukemia Clinical Trials in Baltimore

Showing 1881-1900 of 1,908 trials

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

NCT00116467

The purpose of this study is to evaluate clinical and laboratory safety associated with the administration of GVAX leukemia vaccine and to determine the feasibility of generation of GVAX leukemia vaccine in subjects with acute myelogenous leukemia (AML).

Acute Myelogenous Leukemia

Cell Genesys55 participantsStarted Mar 2001

San Francisco, California, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +1 more locations

TERMINATEDPhase 1< 1 mile

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

NCT00105313

For primary objectives, we will determine the MTD and examine clinical responses and immune cell populations to determine an OBD, and describe the safety and tolerability of MEDI-507. For the secondary objectives we will look at the antitumor activity of MEDI 507, PK, serum concentrations, and immunogenicity of MEDI-507, as well as time courses of depletion and recovery of CD2 positive and total T-Cell populations.

LymphomaLeukemiaCancer

MedImmune LLC80 participantsStarted Feb 2005

Los Angeles, California, United States • New Haven, Connecticut, United States • Washington D.C., District of Columbia, United States +8 more locations

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Leukemia Trials in Other Cities

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART)

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

A Pharmacokinetic and Pharmacodynamic Study of Vincristine in Children With Leukemia

Phase I Study of Intrathecal Topotecan

Evaluation and Natural History of Children With Cancer and AIDS

SU5416 and Carboplatin to Treat Ovarian Cancer

Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) With Yttrium-90 Radiolabeled Anti-Tac

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance Disease

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Urban Environmental Exposures and Childhood Cancer

Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer

Amonafide in Combination With Cytarabine in Secondary AML

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer

Other Conditions in Baltimore